Masaya Igase

591 total citations
50 papers, 364 citations indexed

About

Masaya Igase is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Masaya Igase has authored 50 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Masaya Igase's work include Virus-based gene therapy research (20 papers), Veterinary Oncology Research (17 papers) and Immunotherapy and Immune Responses (9 papers). Masaya Igase is often cited by papers focused on Virus-based gene therapy research (20 papers), Veterinary Oncology Research (17 papers) and Immunotherapy and Immune Responses (9 papers). Masaya Igase collaborates with scholars based in Japan and Indonesia. Masaya Igase's co-authors include Takuya Mizuno, Shunsuke Noguchi, Yuki Nemoto, Masaru Okuda, Yusuke Sakai, Toshihiro Tsukui, Masashi Sakurai, Munekazu NAKAICHI, Kenji Tani and Masahiro Kato and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Masaya Igase

44 papers receiving 357 citations

Peers

Masaya Igase
Judit Fazekas Austria
Lidia Tarone Italy
Aric M. Frantz United States
Richard J. Aguilar United States
Reinhard E. Zachrau United States
Reena Mehta Australia
H Sasai Japan
Shuxia Song China
Lori Clarke United States
Nathalie Baudson Belgium
Judit Fazekas Austria
Masaya Igase
Citations per year, relative to Masaya Igase Masaya Igase (= 1×) peers Judit Fazekas

Countries citing papers authored by Masaya Igase

Since Specialization
Citations

This map shows the geographic impact of Masaya Igase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaya Igase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaya Igase more than expected).

Fields of papers citing papers by Masaya Igase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaya Igase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaya Igase. The network helps show where Masaya Igase may publish in the future.

Co-authorship network of co-authors of Masaya Igase

This figure shows the co-authorship network connecting the top 25 collaborators of Masaya Igase. A scholar is included among the top collaborators of Masaya Igase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaya Igase. Masaya Igase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kyaw, Moe H., et al.. (2025). Isolation of SSEA-3-positive mesenchymal stem cells from equine bone marrow and evaluation of their pluripotency. Research in Veterinary Science. 193. 105736–105736.
2.
Shibutani, Shusaku, Masashi Sakurai, Kazuhito ITAMOTO, et al.. (2025). CXCL8 mediates macrophage migration in canine oral malignant melanoma. Scientific Reports. 15(1). 38854–38854.
3.
Mizuno, Takuya, Yukinari Kato, Toshihiro Tsukui, & Masaya Igase. (2025). Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies. PLoS ONE. 20(6). e0325526–e0325526.
4.
Igase, Masaya, Kazuhito ITAMOTO, Hiroshi Sunahara, et al.. (2024). Proof-of-concept study of the caninized anti-canine programmed death 1 antibody in dogs with advanced non-oral malignant melanoma solid tumors. Journal of Veterinary Science. 25(1). e15–e15. 6 indexed citations
5.
Kato, Taiki, Masashi Sakurai, Yoichi Mizukami, et al.. (2024). Identification of hypoxia‐induced metabolism‐associated genes in canine tumours. Veterinary and Comparative Oncology. 22(3). 367–376.
6.
Sakurai, Masashi, Yumiko Kagawa, Kazuyuki Uchida, et al.. (2023). Cross-reactivity of anti-human programmed cell death ligand 1 (PD-L1) monoclonal antibody, clone 28-8 against feline PD-L1. Journal of Veterinary Medical Science. 85(6). 592–600. 1 indexed citations
7.
Kaneko, Mika K., Takayuki Nakagawa, Kazuo Nishigaki, et al.. (2023). Development of anti-feline PD-1 antibody and its functional analysis. Scientific Reports. 13(1). 6420–6420. 2 indexed citations
8.
Baba, Kenji, et al.. (2023). Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone. Journal of Veterinary Medical Science. 85(10). 1047–1051. 2 indexed citations
9.
Igase, Masaya, Mika Tanabe, Masashi Sakurai, et al.. (2023). Activation of the Akt signalling pathway as a prognostic indicator in canine soft tissue sarcoma. Journal of Comparative Pathology. 206. 44–52. 2 indexed citations
10.
Igase, Masaya, Kenji Tani, Munekazu NAKAICHI, et al.. (2022). Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report. Veterinary and Comparative Oncology. 20(4). 901–905. 19 indexed citations
11.
Igase, Masaya, et al.. (2022). The effect of 5-aminolevulinic acid on canine peripheral blood mononuclear cells. Veterinary Immunology and Immunopathology. 251. 110473–110473. 1 indexed citations
12.
Sakai, Osamu, et al.. (2022). Optimization of Culture Conditions for the Generation of Canine CD20-CAR-T Cells for Adoptive Immunotherapy. In Vivo. 36(2). 764–772. 5 indexed citations
13.
Hasegawa, Yuki, Takako SHIMOKAWA MIYAMA, Kenji Baba, et al.. (2022). Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation. Scientific Reports. 12(1). 15791–15791. 4 indexed citations
14.
Igase, Masaya, Yusuke Sakai, Hiroki Sakai, et al.. (2021). Expression of DEP Domain-Containing 1B in Canine Lymphoma and Other Types of Canine Tumours. Journal of Comparative Pathology. 185. 55–65. 1 indexed citations
15.
Hamamura, Yuki, Takayuki Nakagawa, Masaru Okuda, et al.. (2020). The inhibitory effect of canine interferon gamma on the growth of canine tumors. Research in Veterinary Science. 132. 466–473. 4 indexed citations
16.
Sakai, Osamu, et al.. (2020). Establishment and Characterization of Monoclonal Antibody Against Canine CD8 Alpha. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(4). 129–134. 7 indexed citations
17.
Igase, Masaya, Shusaku Shibutani, Matt Coffey, et al.. (2019). Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma. Molecular Therapy — Oncolytics. 15. 49–59. 14 indexed citations
18.
Igase, Masaya, Shusaku Shibutani, Hiroki Sakai, et al.. (2019). Tenovin-6 induces the SIRT-independent cell growth suppression and blocks autophagy flux in canine hemangiosarcoma cell lines. Experimental Cell Research. 388(1). 111810–111810. 10 indexed citations
19.
Wada, Yusuke, Shunsuke Noguchi, Satoshi Matsuyama, et al.. (2019). MicroRNA-205 enhances the radiosensitivity of canine oral melanoma cells by inhibiting E2F1.. Jūigaku kenkyū/Japanese journal of veterinary research. 67(2). 151–161. 2 indexed citations
20.
Noguchi, Shunsuke, Takashi Mori, Masaya Igase, & Takuya Mizuno. (2015). A novel apoptosis-inducing mechanism of 5-aza-2′-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1. Cancer Letters. 369(2). 344–353. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judit Fazekas Breakdown of academic impact, for papers by Lidia Tarone Breakdown of academic impact, for papers by Aric M. Frantz Breakdown of academic impact, for papers by Richard J. Aguilar Breakdown of academic impact, for papers by Reinhard E. Zachrau Breakdown of academic impact, for papers by Reena Mehta Breakdown of academic impact, for papers by H Sasai Breakdown of academic impact, for papers by Shuxia Song Breakdown of academic impact, for papers by Lori Clarke Breakdown of academic impact, for papers by Nathalie Baudson
Rankless by CCL
2026